Small molecule inhibitors of E. coli primase, a novel bacterial target
2007; Elsevier BV; Volume: 17; Issue: 10 Linguagem: Inglês
10.1016/j.bmcl.2007.02.056
ISSN1464-3405
AutoresAtul Agarwal, Shirley Louise‐May, Jane A. Thanassi, Steven D. Podos, Jijun Cheng, Christy L. Thoma, Cuixian Liu, Jason A. Wiles, David M. Nelson, Avinash Phadke, Barton J. Bradbury, Milind Deshpande, Michael J. Pucci,
Tópico(s)DNA Repair Mechanisms
ResumoBacterial primase is essential for DNA replication in Gram-positive and Gram-negative bacteria. It is also structurally distinct from eukaryotic primases, and therefore an attractive, but under-explored, target for therapeutic intervention. We applied virtual screening to discover primase inhibitors, and subsequently several commercially available analogs of these initial hits showed potent primase inhibition and in vitro antibacterial activity. This work provides a 3D pharmacophore for primase ligands, SAR trends, and leads that can be further optimized.
Referência(s)